We are live on ! Find out more
HBIO icon

Harvard Bioscience

79 hedge funds and large institutions have $82.4M invested in Harvard Bioscience in 2013 Q2 according to their latest regulatory filings, with 79 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

2,620% more call options, than puts

Call options by funds: $136K | Put options by funds: $5K

Holders
79
Holders Change
+79
Holders Change %
% of All Funds
2.58%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
79
Increased
Reduced
Closed
Calls
$136K
Puts
$5K
Net Calls
+$131K
Net Calls Change
+$131K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
SO
26
STRS Ohio
Ohio
$682K +$728K +19,020 New
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$663K +$708K +18,493 New
KCM
28
Kennedy Capital Management
Missouri
$601K +$646K +16,865 New
TCIM
29
TIAA CREF Investment Management
New York
$562K +$600K +15,664 New
TC
30
TFS Capital
Pennsylvania
$494K +$531K +13,861 New
WIC
31
Woodmont Investment Counsel
Tennessee
$477K +$513K +13,390 New
BIM
32
BlackRock Investment Management
Delaware
$408K +$438K +11,446 New
Axa
33
Axa
France
$406K +$433K +11,317 New
Geode Capital Management
34
Geode Capital Management
Massachusetts
$401K +$428K +11,189 New
ACM
35
Advent Capital Management
New York
$360K +$386K +10,095 New
SCM
36
Signia Capital Management
Washington
$278K +$299K +7,808 New
SIM
37
Spark Investment Management
New York
$273K +$295K +7,703 New
Charles Schwab
38
Charles Schwab
California
$239K +$253K +6,608 New
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$210K +$224K +5,863 New
CCMH
40
Cornerstone Capital Management Holdings
New York
$205K +$220K +5,738 New
Citadel Advisors
41
Citadel Advisors
Florida
$183K +$195K +5,085 New
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$168K +$179K +4,682 New
RC
43
RBF Capital
California
$159K +$171K +4,470 New
TA
44
Teachers Advisors
New York
$154K +$165K +4,306 New
BJ
45
BlackRock Japan
Japan
$144K +$154K +4,030 New
SIP
46
Stoneridge Investment Partners
Pennsylvania
$131K +$141K +3,684 New
QCM
47
Quaker Capital Management
Pennsylvania
$126K +$135K +3,535 New
CBOA
48
Commonwealth Bank of Australia
Australia
$111K +$119K +3,108 New
NFA
49
Nationwide Fund Advisors
Ohio
$109K +$117K +3,047 New
PAM
50
Panagora Asset Management
Massachusetts
$105K +$112K +2,934 New

HBIO Hedge Fund Activity: Q2 2013 in Review

79 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Harvard Bioscience (HBIO) for Q2 2013, worth a combined $82.4M.

Buyers outnumbered sellers: 79 funds opened new HBIO positions and 0 closed out — a net gain of 79 holders — while 0 added to existing stakes and 0 trimmed.

  • 79 institutional investors held Harvard Bioscience (HBIO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $82.4M of Harvard Bioscience stock for Q2 2013.
  • 79 funds opened new Harvard Bioscience positions in Q2 2013 and 0 closed out, a net change of +79 holders.

Based on aggregated 13F filings for Q2 2013.